CalciMedica Inc. (NASDAQ: CALC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CALCIMEDICA INC.

CalciMedica Inc. (NASDAQ: CALC)
Listen to this Section


$0.99
+0.1390 ( +16.34% ) 2.3M

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Clinical Trial Pipeline Stages


Drug Name Stage
Auxora™DetailsAcute Pancreatitis Phase 2b
Auxora™DetailsAsparaginase-induced pancreatic toxicity Phase 2
Auxora™DetailsAcute Kidney Injury, Kidney disease Phase 2
GB-102 (Pan-VEGF inhibitor)DetailsEye disease , Wet age-related macular degeneration , Age-related macular degeneration Failed
GB-102 (Pan-VEGF inhibitor)DetailsDiabetes, Eye disease , Diabetic macular edema Failed

Market Data


Open $0.99
Previous Close $0.85
Volume 2.3M
Market Cap $13.43M
Day Range $0.85 - $1.11
52 Week Range $0.46 - $7.20
Shares Outstanding 15.80M
Change % +16.34%
Net Change ▲ 0.1390
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -376,293.00

Date Type Amount Purchased Purchaser
2025-09-22 Buy 2500.00 Roberts Eric W
2025-09-22 Buy 2500.00 Roberts Eric W
2025-09-22 Buy 2500.00 Roberts Eric W
2025-09-17 Buy 3400.00 Roberts Eric W
2025-09-17 Buy 3400.00 Roberts Eric W
2025-09-17 Buy 3400.00 Roberts Eric W
2025-09-15 Buy 5000.00 Roberts Eric W
2025-09-11 Buy 2343.00 Roberts Eric W
2025-09-02 Buy 9200.00 Roberts Eric W
2025-09-02 Buy 9200.00 Roberts Eric W

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 21, 2025
4 Insider transactions 1 Aug 19, 2025
4 Insider transactions 1 Aug 18, 2025
10-q Quarterly Reports 64 Aug 12, 2025
8-k 8K-related 12 Aug 12, 2025
schedule Other 1 Aug 05, 2025
4 Insider transactions 1 Jul 29, 2025
4 Insider transactions 1 Jul 23, 2025
4 Insider transactions 1 Jul 22, 2025
4 Insider transactions 1 Jul 21, 2025

Latest News


× Before browsing our site, please accept our cookies policy